[RNAZ] QoQ Quarter Result on 30-Sep-2021 [#Q3]

Stock
[RNAZ] TransCode Therapeutics, Inc.
Announcement Date
15-Nov-2021
Financial Year
2021
Quarter
30-Sep-2021 [#Q3]
Profit Trend
QoQ- -139.00%
YoY- -67.39%
Quarter Report
RNAZ's Result
RNAZ's Financial Summary
View:
Show?
Quarter Result
30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 CAGR
Revenue 0 0 0 0 0 0 0 -
PBT -4,671 -3,470 -5,910 -2,330 2,771 -4,485 -802 224.75%
Tax -36 -7 2,924 -30 -3,126 3,983 369 -
NP -4,635 -3,463 -8,834 -2,300 5,897 -4,485 -802 223.08%
Tax Rate - - - - 112.83% - - -
Total Cost 4,635 3,463 8,834 2,300 -5,897 4,485 802 223.08%
Ratio Analysis
30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 CAGR
NP Margin 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
Per Share
30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 CAGR
EPS -289.70 -216.41 -552.15 -164.25 589.73 -278.07 -100.46 102.99%
EPS Diluted -285.73 -213.45 -547.70 -159.60 589.73 -278.07 -100.46 101.12%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.